Hostname: page-component-848d4c4894-m9kch Total loading time: 0 Render date: 2024-05-31T20:17:52.804Z Has data issue: false hasContentIssue false

Introducing ethanol ablation as a treatment for thyroid cysts in the emergency setting

Published online by Cambridge University Press:  17 August 2022

L Robb*
Affiliation:
Department of Plastic and Reconstructive Surgery, Ninewells Hospital, NHS Tayside, Dundee, Scotland, UK
S Y Hey
Affiliation:
Department of Otolaryngology, St John's Hospital at Howden, NHS Lothian, Livingston, Scotland, UK
H Reid
Affiliation:
Department of Radiology, St John's Hospital at Howden, NHS Lothian, Livingston, Scotland, UK
I J Nixon
Affiliation:
Department of Otolaryngology, St John's Hospital at Howden, NHS Lothian, Livingston, Scotland, UK
*
Author for correspondence: Ms Lydia Robb, Plastic Surgery Department, NHS Tayside, Ninewells Hospital, Dundee DD1 9SY, Scotland, UK E-mail: Lydia.robb@doctors.org.uk

Abstract

Background

Ethanol ablation for the treatment of thyroid cysts has been well documented in the literature as a safe, effective treatment option in the elective setting. This study demonstrates the use of ethanol ablation in the emergency setting.

Methods

Three patients presenting with airway-threatening compressive symptoms secondary to a thyroid cyst were treated with ethanol ablation within 24 hours of presentation to hospital.

Results

All patients had symptom resolution at a median of nine months follow up post procedure. Sixty-six per cent of patients required only one treatment. There was a median of 100 per cent radiological resolution of the cystic component. The median Glasgow Benefit Inventory score was +27.7, similar to that for tonsillectomy.

Conclusion

Ethanol ablation is a safe, cost-effective and efficient treatment option for thyroid cysts in the acute setting.

Type
Clinical Records
Copyright
Copyright © The Author(s), 2022. Published by Cambridge University Press on behalf of J.L.O. (1984) LIMITED

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

Ms L Robb takes responsibility for the integrity of the content of the paper

References

Paschke, R, Hegedüs, L, Alexander, E, Valcavi, R, Papini, E, Gharib, H. Thyroid nodule guidelines: agreement, disagreement and need for future research. Nat Rev Endocrinol 2011;7:354–6110.1038/nrendo.2011.1CrossRefGoogle ScholarPubMed
Papini, E, Pacella, CM. Diagnosis of endocrine disease: thyroid ultrasound (US) and US-assisted procedure: from shadows into an array of applications. Eur J Endocrinol 2014;170:133–4610.1530/EJE-13-0917CrossRefGoogle ScholarPubMed
Hegedüs, L, Frasoldati, A, Negro, R, Papini, E. European Thyroid Association survey on use of minimally invasive techniques for thyroid nodules. Eur Thyroid J 2020;9:19420410.1159/000506513CrossRefGoogle ScholarPubMed
Papini, E, Pacella, CM, Solbiati, LA, Achille, G, Barbaro, D, Bernardi, S et al. Minimally-invasive treatments for benign thyroid nodules: a Delphi-based consensus statement from the Italian minimally-invasive treatments of the thyroid (MITT) group. Int J Hyperthermia 2019;36:376–8210.1080/02656736.2019.1575482CrossRefGoogle ScholarPubMed
Nixon, IJ, Angelos, P, Shaha, AR, Rinaldo, A, Williams, MD, Ferlito, A. Image-guided chemical and thermal ablations for thyroid disease: review of efficacy and complications. Head Neck 2018;40:2103–1510.1002/hed.25181CrossRefGoogle ScholarPubMed
National Institute for Health and Care Excellence. Thyroid Disease: Assessment and Management. NICE Guideline 145 [NG145]. London: NICE, 2019;53–5Google Scholar
Hahn, SY, Shin, JH, Na, DG, Ha, EJ, Ahn, HS, Lim, HK et al. Ethanol ablation of the thyroid nodules: 2018 consensus statement by the Korean Society of Thyroid Radiology. Korean J Radiol 2018;20:609–2010.3348/kjr.2018.0696CrossRefGoogle Scholar
Del Prete, S, Caraglia, M, Russo, D. Percutaneous ethanol injection efficacy in the treatment of large symptomatic thyroid cystic nodules: ten-year follow-up of a large series. Thyroid 2002;12:815–2110.1089/105072502760339398CrossRefGoogle ScholarPubMed
Suh, CH, Baek, JH. Ethanol ablation of predominantly cystic thyroid nodules: evaluation of recurrence rate and factors related to recurrence. Clin Radiol 2015;70:42–710.1016/j.crad.2014.09.008CrossRefGoogle ScholarPubMed
Bennedbaek, F, Hegedüs, L. Treatment of recurrent thyroid cysts with ethanol: a randomized double-blind controlled trial. J Clin Endocrinol Metab 2003;88:5773–710.1210/jc.2003-031000CrossRefGoogle ScholarPubMed
Sung, JY, Baek, JH, Kim, KS, Lee, D, Yoo, H, Kim, JK et al. Single-session treatment of benign cystic thyroid nodules with ethanol versus radiofrequency ablation: a prospective randomized study. Radiology 2013;269:29330010.1148/radiol.13122134CrossRefGoogle ScholarPubMed
Hey, SY, Robb, L, Gammack, P, Smith, DA, Rodrigues, MA, Summers, D et al. Introducing an ethanol ablation service for recurrent symptomatic thyroid cysts within the NHS--a prospective study of twenty-six patients. Clin Otolaryngol 2021;46:645–910.1111/coa.13697CrossRefGoogle ScholarPubMed
Jang, S, Baek, J, Kim, J. How to manage the patients with unsatisfactory results after ethanol ablation for thyroid nodules: role of radiofrequency ablation. Eur J Radiol 2012;81:905–1010.1016/j.ejrad.2011.02.039CrossRefGoogle Scholar